JPS6326751B2 - - Google Patents
Info
- Publication number
- JPS6326751B2 JPS6326751B2 JP55069991A JP6999180A JPS6326751B2 JP S6326751 B2 JPS6326751 B2 JP S6326751B2 JP 55069991 A JP55069991 A JP 55069991A JP 6999180 A JP6999180 A JP 6999180A JP S6326751 B2 JPS6326751 B2 JP S6326751B2
- Authority
- JP
- Japan
- Prior art keywords
- group
- butoxy
- melting point
- carried out
- nitro
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/70—Sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C201/00—Preparation of esters of nitric or nitrous acid or of compounds containing nitro or nitroso groups bound to a carbon skeleton
- C07C201/06—Preparation of nitro compounds
- C07C201/12—Preparation of nitro compounds by reactions not involving the formation of nitro groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/36—Sulfur atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Cardiology (AREA)
- Hospice & Palliative Care (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Quinoline Compounds (AREA)
Description
本発明の目的は一般式
なるカルボスチリル誘導体の新規製造方法であ
る。一般式において、Wはビニレン基、エチレ
ン基または2−メチル−ビニレン基を表わし、D
は2〜6個の炭素原子を有する直鎖状もしくは分
枝鎖状アルキレン基を表わし、mは1を表わし、
R1は水素原子を表わし、R2は3〜6個の炭素原
子を有するシクロアルキル基、フエニル基、ナフ
チル基、フエニルアルキル基、ピリジル基または
キノリル基を表わし(但し上記の芳香族核はアル
キル、ヒドロキシ、メトキシ、アミノ、シクロヘ
キシル、フエニル又はハロゲン原子によつて置換
されていてもよい)、そしてR3およびR4は同一で
も異なつていてもよく、水素原子もしくはハロゲ
ン原子またはアルキル基を表わす。
一般式なる化合物は有用な薬理学的特性を有
する。これらは陽性の筋変力作用を有するだけで
なく特に抗血栓症活性を有する。
この抗血栓症作用について下記の化合物に対し
薬理試験を行なつた:
(本発明方法による化合物)
A=6−(4−フエニルスルフイニルブトキシ)−
3,4−ジヒドロカルボスチリル
B=6−〔4−(2−ピリジルスルフイニル)−ブ
トキシ〕−3,4−ジヒドロカルボスチリル
C=6−(2−フエニルスルフイニル−エトキシ)
−3,4−ジヒドロカルボスチリル
D=6−(4−ベンジルスルフイニル−ブトキシ)
−3,4−ジヒドロカルボスチリル
E=6−〔4−(4−クロロフエニルスルフイニ
ル)−ブトキシ〕−3,4−ジヒドロカルボスチ
リル
F=6−(4−シクロヘキシルスルフイニル−ブ
トキシ)−3,4−ジヒドロカルボスチリル
G=6−〔4−(2−ナフチルスルフイニル)−ブ
トキシ〕−3,4−ジヒドロカルボスチリル
H=6−〔4−(2−メトキシフエニルスルフイニ
ル)−ブトキシ〕−3,4−ジヒドロカルボスチ
リル
I=6−(4−フエニルスルフイニル−ブトキシ)
−カルボスチリル
K=6−〔4−(4−ヒドロキシ−3,5−ジ−
tert−ブチル−フエニルスルフイニル)−ブト
キシ〕カルボスチリル
L=6−〔4−(3,4−ジクロロフエニルスルフ
イニル)−ブトキシ〕カルボスチリル
M=4−メチル−6−(4−フエニルスルフイニ
ル−ブトキシ)−カルボスチリル
N=6−〔4−(2,5−ジクロロフエニルスルフ
イニル)−ブトキシ〕−3,4−ジヒドロカルボ
スチリル
O=6−〔4−(3,4−ジクロロフエニルスルフ
イニル)−ブトキシ〕−3,4−ジヒドロ−カル
ボスチリル
P=6−〔4−(3,4−ジクロロ−フエニルスル
フイニル)−ブトキシ〕−3,4−ジヒドロカル
ボスチリル
Q=6−〔4−(2−ピリジルスルフイニル)−ブ
トキシ〕カルボスチリル
R=4−メチル−6−〔4−(2−ピリジルスルフ
イニル)−ブトキシ〕カルボスチリル
S=6−〔4−(4−シクロヘキシル−フエニルス
ルフイニル)−ブトキシ〕カルボスチリル
T=6−〔4−(4−ビフエニリルスルフイニル)
−ブトキシ〕カルボスチリル
U=6−〔4−(2−キノリルスルフイニル)−ブ
トキシ〕カルボスチリル
V=6−〔4−(4−tert、ブチル−フエニルスル
フイニル)−ブトキシ〕−3,4−ジヒドロカル
ボスチリル
W=6−〔4−(4−ビフエニリルスルフイニル)
−ブトキシ〕−3,4−ジヒドロカルボスチリ
ル
X=6−〔2−(フエニルスルフイニルメチル)−
ベンジルオキシ〕−3,4−ジヒドロカルボス
チリル
Y=5−ニトロ−6−(4−フエニルスルフイニ
ル−ブトキシ)−カルボスチリル
Z=6−(6−フエニルスルフイニル−ヘキソキ
シ)−3,4−ジヒドロカルボスチリル
(対照化合物)
AA=6−(3−エチルチオ−プロポキシ)−3,
4−ジヒドロカルボスチリル
BB=6−(3−エチルスルホニル−プロポキシ)
−3,4−ジヒドロカルボスチリル
CC=6−(3−エチルチオ−プロポキシ)−カル
ボスチリル
DD=6−(3−エチルスルホニルプロポキシ)−
カルボスチリル。
試験方法:
ボーンおよびクロス(Born and Cross)の方
法(J.Physiol.170巻、397頁(1964年))による血
小板凝集の測定
血小板凝集は健康な人の血小板の豊富な血しよ
うにおいて測定した。光学濃度の減少をアデノシ
ン−ジホスフエートまたはコラーゲンを添加した
後分光光学的に測定し、記録した。この濃度曲線
の傾斜角から凝集速度を計算した(Vmax)。光
学濃度は最大量の光が透過するその曲線上の点と
して示される(O.D.)。
表中のEC50の欄は光学濃度を示す。少量では
あるが不可逆凝集を生ぜしめるのに十分なコラー
ゲン量を選択する。最大の凝集を起こさせるため
約0.01mlのコラーゲン溶液を1mlの血小板の豊富
な血しように加えた(Hormonchemie社、ミユ
ンヘン、の市販のコラーゲン)。アデノシン−ジ
ホスフエート(ADP)量はそのBORN曲線の第
1相のみを生ずるように選択した。ADPの必要
量は約1.10-6mol/であつた。Boehringer
Mannheim社の市販のADPを用いた。
血小板凝集の50%阻止を惹起させる化合物の量
をグラフから測定した(EC50)
The object of the present invention is to This is a new method for producing carbostyril derivatives. In the general formula, W represents a vinylene group, ethylene group or 2-methyl-vinylene group, and D
represents a linear or branched alkylene group having 2 to 6 carbon atoms, m represents 1,
R 1 represents a hydrogen atom, and R 2 represents a cycloalkyl group, phenyl group, naphthyl group, phenylalkyl group, pyridyl group, or quinolyl group having 3 to 6 carbon atoms (however, the above aromatic nucleus alkyl, hydroxy, methoxy, amino, cyclohexyl, phenyl or halogen atom), and R 3 and R 4 may be the same or different and may be substituted by a hydrogen atom or a halogen atom or an alkyl group. represent Compounds of the general formula have useful pharmacological properties. They not only have a positive inotropic effect but also particularly antithrombotic activity. Pharmacological tests were conducted on the following compounds for this antithrombotic effect: (Compound according to the method of the present invention) A=6-(4-phenylsulfinylbutoxy)-
3,4-dihydrocarbostyryl B=6-[4-(2-pyridylsulfinyl)-butoxy]-3,4-dihydrocarbostyryl C=6-(2-phenylsulfinyl-ethoxy)
-3,4-dihydrocarbostyryl D=6-(4-benzylsulfinyl-butoxy)
-3,4-dihydrocarbostyryl E=6-[4-(4-chlorophenylsulfinyl)-butoxy]-3,4-dihydrocarbostyryl F=6-(4-cyclohexylsulfinyl-butoxy)- 3,4-dihydrocarbostyryl G=6-[4-(2-naphthylsulfinyl)-butoxy]-3,4-dihydrocarbostyryl H=6-[4-(2-methoxyphenylsulfinyl)- butoxy]-3,4-dihydrocarbostyryl I = 6-(4-phenylsulfinyl-butoxy)
-Carbostyryl K=6-[4-(4-hydroxy-3,5-di-
tert-butyl-phenylsulfinyl)-butoxy]carbostyryl L = 6-[4-(3,4-dichlorophenylsulfinyl)-butoxy]carbostyryl M = 4-methyl-6-(4-phenylsulfinyl) rufinyl-butoxy)-carbostyryl N=6-[4-(2,5-dichlorophenylsulfinyl)-butoxy]-3,4-dihydrocarbostyryl O=6-[4-(3,4-dichloro phenylsulfinyl)-butoxy]-3,4-dihydro-carbostyryl P=6-[4-(3,4-dichloro-phenylsulfinyl)-butoxy]-3,4-dihydrocarbostyryl Q=6 -[4-(2-pyridylsulfinyl)-butoxy]carbostyryl R=4-methyl-6-[4-(2-pyridylsulfinyl)-butoxy]carbostyryl S=6-[4-(4 -cyclohexyl-phenylsulfinyl)-butoxy]carbostyryl T=6-[4-(4-biphenylylsulfinyl)
-butoxy]carbostyryl U=6-[4-(2-quinolylsulfinyl)-butoxy]carbostyryl V=6-[4-(4-tert, butyl-phenylsulfinyl)-butoxy]-3 ,4-dihydrocarbostyryl W=6-[4-(4-biphenylylsulfinyl)
-butoxy]-3,4-dihydrocarbostyryl X=6-[2-(phenylsulfinylmethyl)-
benzyloxy]-3,4-dihydrocarbostyryl Y = 5-nitro-6-(4-phenylsulfinyl-butoxy)-carbostyryl Z = 6-(6-phenylsulfinyl-hexoxy)-3,4 -dihydrocarbostyryl (control compound) AA=6-(3-ethylthio-propoxy)-3,
4-dihydrocarbostyryl BB=6-(3-ethylsulfonyl-propoxy)
-3,4-dihydrocarbostyryl CC=6-(3-ethylthio-propoxy)-carbostyryl DD=6-(3-ethylsulfonylpropoxy)-
Calbostyril. Test method: Determination of platelet aggregation according to the method of Born and Cross (J. Physiol. Vol. 170, p. 397 (1964)) Platelet aggregation was determined in platelet-rich blood glands of healthy individuals. The decrease in optical density was measured and recorded spectrophotometrically after addition of adenosine-diphosphate or collagen. The aggregation rate was calculated from the slope angle of this concentration curve (Vmax). Optical density is indicated as the point on the curve where the maximum amount of light is transmitted (OD). The EC 50 column in the table indicates optical density. Select a small but sufficient amount of collagen to cause irreversible aggregation. Approximately 0.01 ml of collagen solution was added to 1 ml of platelet-rich blood to induce maximum aggregation (commercially available collagen from Hormonchemie, Myuncheng). The amount of adenosine-diphosphate (ADP) was selected to produce only the first phase of the BORN curve. The required amount of ADP was approximately 1.10 -6 mol/. Boehringer
Commercially available ADP from Mannheim was used. The amount of compound that causes 50% inhibition of platelet aggregation was determined from the graph (EC 50 )
【表】【table】
【表】
一般式なるカルボスチリルは次の方法に従つ
ても製造され得ることが認められている。
反応混合物中に適宜に生成される一般式
(式中D、W、R1ないしR4およびmは上記定義
と同じであり、Zは求核的に変換しうる基たとえ
ばヒドロキシ基、ハロゲン原子、アルコキシ、ア
リールオキシ又はアルアルコキシ基を表わす)
なる化合物の環化。
環化は縮合剤たとえば適当に硫酸、濃塩酸、リ
ン酸又は塩化チオニルの存在下に、溶媒たとえば
氷酢酸、テトラヒドロフラン、ジオキサン、クロ
ロホルム、トリエン、エタノール中にて又は用い
た過剰の縮合剤中にて高められた温度で、たとえ
ば50と200℃との間の温度で、しかし好ましくは
80と150℃との間の温度で行われるのが好ましい。
しかしこの反応はさらに溶媒および(又は)縮合
剤を用いずに行うこともできる。
一般式なる化合物を単離する必要はなく、こ
れをそのまま出発物質として用いる。この化合物
はその場で相当するニトロ化合物から、たとえば
ニトロ基を水素で水素添加触媒たとえばパラジウ
ム−木炭、パラジウム−炭酸カルシウムもしくは
パラジウム−炭酸カルシウム+酢酸鉛(リンドラ
ー触媒)の存在下に還元することによつて、金属
たとえば鉄、スズもしくは亜鉛で酸の存在下に還
元することによつて、塩たとえば鉄()−硫酸
塩、亜鉛()−塩化物、クロム−()−塩化物
もしくは亜二チオン酸ナトリウムで還元すること
によつて又はヒドラジンでラネー−ニツケルの存
在下に還元することによつて行われる。
相当するニトロ化合物中でmが1を表わす場合
には、ニトロ基の還元を当量の必要な還元剤で、
たとえば金属塩たとえば鉄−()−硫酸塩、スズ
−()−塩化物、クロム−()−塩化物もしくは
亜二チオン酸ナトリウムで、又は水素で不活性化
水素添加触媒の存在下に、たとえばパラジウム−
炭酸カルシウム+酢酸鉛の存在下に行うのが適当
である。もしも、たとえば、この還元をパラジウ
ム−木炭の存在下に行うと、スルホキシド基もま
た一部還元される。
さらに、相当するニトロ化合物中のWがビニレ
ン基を表わす場合には、この基を水素添加によつ
て相当するエチレン基にすることができ、特に還
元を接触的に活性化水素で、たとえばパラジウム
−木炭の存在下に水素で行う場合にはそうであ
る。
出発物質として用いられる一般式で示される
化合物は文献から一部知られており、それらは既
知方法によつて得られうる。すなわち、一般式
なる化合物は相当するニトロ化合物を還元するこ
とによつて得られ、一方このニトロ化合物は相当
する2−ニトロ−5−ヒドロキシ化合物を相当す
るα,ωジハロゲンアルカンでアルキル化し、次
いで相当するメルカプト化合物と反応させ、かつ
適宜に過酸化水素で続いて酸化することによつて
得られる。
次の例は本発明を例証するものである。
例 1(参考例)
6−〔4−(2−ピリジルスルホニル)−ブトキ
シ〕−3,4−ジヒドロ−カルボスチリル
(a) 2−ニトロ−5−ヒドロキシ−ケイ皮酸メチ
ルエステル
21.0gの2−ニトロ−5−ヒドロキシ−ケイ
皮酸〔エス.エヌ.チヤクラバーテイ(S.N.
Chakravarti)およびピー・エル・エヌ・ラオ
(P.L.N.Rao)、ケム.ササ.(Chem.Soc.)
1938、172〕を200mlのメタノール中に溶かす。
86mlの塩化チオニルを撹拌しながらこの溶液へ
45分以内に滴下添加するが、この際温度は36℃
まで高められる。さらに25分間撹拌後、この反
応混合物を氷浴上で冷却し、18.6gの2−ニト
ロ−5−ヒドロキシ−ケイ皮酸メチル−エステ
ルを得る。
融点:201−203℃。
(b) 2−ニトロ−5−ブロムブトキシ−ケイ皮酸
メチルエステル
200mlのジメチルスルホキシド中の22.3gの
2−ニトロ−5−ヒドロキシ−ケイ皮酸メチル
エステル、59.7mlの1,4−ジブロムブタンお
よび13.8gの炭酸カリウムの混合物を室温で15
時間撹拌する。800mlの水を添加後、この反応
混合物をクロロホルムで抽出し、溶媒を蒸発さ
せた後に31.7gの2−ニトロ−5−ブロムブト
キシ−ケイ皮酸メチルエステルを単離する。
融点:60.5−63℃。
(c) 2−ニトロ−5−〔4−(2−ピリジルメルカ
プト)−ブトキシ〕−ケイ皮酸メチルエステル
100mlのジメチルスルホキシド中の5gの炭
酸カリウムと4.0gの2−メルカプトピリジン
の混合物を60分間撹拌後、そこへ10.75gの2
−ニトロ−5−ブロム−ブトキシ−ケイ皮酸メ
チルエステルを添加し、この混合物を室温で18
時間撹拌する。400mlの水を添加し、油状反応
生成物をエーテル抽出によつて単離する。
収量:11.0g(理論値94.2%)。
(d) 2−ニトロ−5−〔4−(2−ピリジルスルホ
ニル)−ブトキシ〕−ケイ皮酸メチルエステル
7.0gの2−ニトロ−5−〔4−(2−ピリジ
ルメルカプト)−ブトキシ〕−ケイ皮酸メチルエ
ステルを70mlの酢酸中に溶かす。5.0mlの35%
過酸化水素を添加し、この混合物を3日間室温
に維持する。氷酢酸を留去後、反応生成物をク
ロロホルム/メタノールから再結晶させる。
収量:3.5g(理論値の46.2%)。
融点:118−121℃。
(e) 6−〔4−(2−ピリジルスルホニル)−ブト
キシ〕−3,4−ジヒドロカルボスチリル
2.1gの2−ニトロ−5−〔4−(2−ピリジ
ルスルホニル)−ブトキシ〕−ケイ皮酸メチルエ
ステルを20mlの氷酢酸に溶かし、これを0.5g
の10%パラジウム−木炭を用い3バールの水素
圧にて室温で水素添加する。氷酢酸を留去後、
残留物を20mlの濃塩酸で4時間還流する。反応
生成物を2n水酸化ナトリウム溶液で中性にし、
かつクロロホルムで抽出する。蒸発残留物をキ
シレンから再結晶させる。
収量:1.06g(理論値の55.6%)。
融点:121−123℃。
例 2(参考例)
6−〔4−(2−ピリジルスルホニル)−ブトキ
シ〕−カルボスチリル
2.0gの2−ニトロ−5−〔4−(2−ピリジル
スルホニル)−ブトキシ〕−ケイ皮酸メチルエステ
ルと3.0gの亜二チオン酸ナトリウムの混合物を
20mlの水と10mlのエタノール中にて4時間還流
し、清澄な溶液を得る。この反応混合物を蒸発さ
せ、20mlの濃塩酸と一緒に3時間還流する。2n
水酸化ナトリウム溶液で中和した後、反応生成物
をエーテル抽出し、キシレンから少量のジメチル
ホルムアミドの添加によつて再結晶させる。
収量:0.5g(理論値の29%)
融点:176−179℃。
この物質は、還元剤として亜ニチオン酸ナトリ
ウムの代わりにリンドラ−触媒(鉛によつて部分
的に不活性化されたパラジウム)を用いれば同様
の方法で得られうる。それによつてニトロ基のみ
を還元し、6−〔4−(2−ピリジルスルホニル)
−ブトキシ〕−カルボスチリルを濃塩酸での処理
後に得る。
例 3(参考例)
6−〔4−(3,4−ジクロルフエニルメルカプ
ト)−ブトキシ〕−カルボスチリル
4.5gの2−ニトロ−5−〔4−(3,4−ジク
ロルフエニルメルカプト)−ブトキシ〕−ケイ皮酸
メチルエステル(融点:91−92℃、2−ニトロ−
5−ヒドロキシ−ケイ皮酸メチル−エステルと4
−(3,4−ジクロルフエニルメルカプト)−ブチ
ル−ブロミドから製造される)を、50mlのエタノ
ールと50mlの水からなる混合物中で4時間還流す
る。溶媒を除去した後、残留物を4時間100mlの
濃塩酸と一緒に還流する。得られた結晶性物質を
吸収ろ過し、かつキシレンから再結晶させる。
収量:1.2g(理論値の31%)。
融点:144℃。
例 4
6−〔4−(3,4−ジクロルフエニル−スルフ
イニル)−ブトキシ〕−カルボスチリル
(a) 2−ニトロ−5−〔4−(3,4−ジクロルフ
エニルスルフイニル)−ブトキシ〕−ケイ皮酸メ
チルエステル
11.2gの2−ニトロ−5−ヒドロキシ−ケイ
皮酸メチルエステルを150mlのジメチルスルホ
キシド中に溶かす。この溶液を9.2gの無水炭
酸カリウムと混合し、かつ15分間撹拌する。
16.5gの4−(3,4−ジクロルフエニルスル
フイニル)−ブチルブロミドを添加し、かつ混
合物を40時間室温で撹拌する。反応混合物を
1000mlの水で希釈し、かつ200mlのクロロホル
ムと100mlのメタノールとの混合物で抽出する。
有機溶媒を蒸発させると油状残留物が得られ、
エーテルで処理するとこれは結晶形として得ら
れる。
収量:13g(理論値の57%)。
融点:78−81℃
(b) 2−アミノ−5−〔4−(3,4−ジクロルフ
エニルスルフイニル)−ブトキシ〕−ケイ皮酸メ
チルエステル
4.2gの2−ニトロ−5−〔4−(3,4−ジ
クロルフエニルスルフイニル)−ブトキシ〕−ケ
イ皮酸メチルエステルを、100mlのメタノール
中にて0.5gのリンドラー触媒(酢酸鉛によつ
て部分的に不活性化されたパラジウム炭酸カル
シウム)を用いて3バールの水素圧で、室温に
て12時間水素添加する。触媒を除去した後溶媒
を蒸発させ、この樹脂質の暗色残留物を次の反
応に直接用いる。
(c) 6−〔4−(3,4−ジクロルフエニルスルフ
イニル)−ブトキシ〕−カルボスチリル
前記の2−アミノ−5−〔4−(3,4−ジク
ロルフエニルスルフイニル)−ブトキシ〕−ケイ
皮酸メチルエステルを、80mlの5n塩酸と一緒
に3時間沸騰するまで加熱し、かつ熱ろ過す
る。ろ液を冷却後、無色結晶を得る。
収量:2.1g(理論値の56%)。
融点:191−192℃。
もしも前記反応方法において鉄粉末と80%酢
酸を2−ニトロ−5−〔4−(3,4−ジクロル
フエニルスルフイニル)−ブトキシ〕−ケイ皮酸
メチルエステルの環元に薬剤として用いても、
さらに6−〔4−(3,4−ジクロルフエニルス
ルフイニル)−ブトキシ〕−カルボスチリルが反
応生成物として得られる。
例 5
2.3gの2−ニトロ−5−(3,4−ジクロルフ
エニルスルフイニル)−ブトキシ−ケイ皮酸メチ
ルエステルを例5bと同様に20mlの氷酢酸中にて
0.2gのパラジウム−木炭を用いて3バールの水
素圧で室温にて7時間水素添加する。触媒を除去
した後、氷酢酸を留去し、かつ残留物を40mlの
5n塩酸と一緒に1時間沸騰するまで加熱する。
反応混合物を少量のクロロホルムで抽出し、かつ
薄層プレート(メルクシリカゲル60F254)上にて
塩化エチレン/メタノール=9:1でクロマトグ
ラフイーによつて分離する。得られた化合物を
UV−光とヨウ素スプレーで噴霧することによつ
て確認する。
Rf値:0.30:6−〔4−(3,4−ジクロルフエニ
ルスルフイニル)−ブトキシ〕−カルボスチリ
ル。ヨウ素スプレーで青−すみれ色。
Rf値:0.42:6−〔4−(3,4−ジクロルフエニ
ルメルカプト)−ブトキシ〕−カルボスチリル。
ヨウ素スプレーで最初橙黄色、次に徐々に灰−
すみれ色。
Rf値:0.45:6−〔4−(3,4−ジクロルフエニ
ル−スルフイニル)−ブトキシ〕−3,4−ジヒ
ドロ−カルボスチリル。ヨウ素スプレーで強い
橙黄色。
Rf値:0.57:6−〔4−(3,4−ジクロルフエニ
ル−メルカプト)−ブトキシ〕−3,4−ジヒド
ロ−カルボスチリル。ヨウ素スプレーで薄卵黄
色。
次の化合物は上記の例と同じように製造され
る。
6−(4−フエニルスルフイニルブトキシ)−
3,4−ジヒドロカルボスチル
融点:144.5−145.5℃
6−〔4−(2−ピリジルスルフイニル)−ブト
キシ〕−3,4−ジヒドロカルボスチリル
融点:144.5−146℃。
6−(2−フエニルスルフイニル−エトキシ)−
3,4−ジヒドロ−カルボスチリル
融点:171−172℃
6−(4−ベンジルスルフイニル−ブトキシ)−
3,4−ジヒドロカルボスチリル
融点:141.5−142℃
6−〔4−(4−クロルフエニルスルフイニル)
−ブトキシ〕−3,4−ジヒドロカルボスチリル
融点:148−149.5℃
6−(4−シクロヘキシルスルフイニル−ブト
キシ)−3,4−ジヒドロカルボスチリル
融点:153−155.5℃
6−〔4−(2−ナフチルスルフイニル)−ブト
キシ〕−3,4−ジヒドロカルボスチリル
融点:147.5−148.5℃
6−〔4−(2−メトキシフエニルスルフイニ
ル)−ブトキシ〕−3,4−ジヒドロカルボスチリ
ル
融点:130.5−133℃
6−(4−フエニルスルフイニル−ブトキシ)−
カルボスチリル
融点:181−182.5℃
6−〔4−(4−ヒドロキシ−3,5−ジ−tert
−ブチル−フエニルスルフイニル)−ブトキシ〕−
カルボスチリル
融点:192−194℃
6−〔4−(3,4−ジクロルフエニルスルフイ
ニル)−ブトキシ〕−カルボスチリル
融点:191−196℃
4−メチル−6−(4−フエニルスルフイニル
−ブトキシ)−カルボスチリル
融点:167−168℃
6−〔4−(2,5−ジクロルフエニルスルフイ
ニル)−ブトキシ〕−3,4−ジヒドロカルボスチ
リル
融点:185−186℃
6−〔4−(2−ナフチル−スルフイニル)−ブ
トキシ〕−3,4−ジヒドロカルボスチリル
融点:147.5−148.5℃
6−〔4−(4−ビフエニリルスルフイニル)−
ブトキシ〕−カルボスチリル
融点:196−197℃
6−〔4−(2−キノリルスルフイニル)−ブト
キシ〕−カルボスチリル
融点:197−198℃
6−〔4−シクロヘキシルスルフイニル)−ブト
キシ〕−カルボスチリル
融点:169−170℃
5−ブロム−6−(4−フエニルスルフイニル
−ブトキシ)−カルボスチリル
融点:190−191℃
6−〔4−(3,5−ジブロム−4−アミノフエ
ニルスルフイニル)−ブトキシ〕−3,4−ジヒド
ロカルボスチリル
融点:144−146℃
6−〔4−(3,5−ジブロム−4−アミノフエ
ニルスルフイニル)−ブトキシ〕−カルボスチリル
融点:205−207℃
6−〔4−(4−シクロヘキシルフエニルスルフ
イニル)−ブトキシ〕−3,4−ジヒドロカルボス
チリル
融点:155−157℃
6−〔4−(4−シクロヘキシルフエニルスルフ
イニル)−ブトキシ〕−カルボスチリル
融点:188−190℃
6−〔4−(4−tert−ブチルフエニルスルフイ
ニル)−ブトキシ〕−カルボスチリル
融点:164−166℃
6−〔4−(3,4−ジクロルフエニルスルフイ
ニル)−ブトキシ〕−3,4−ジヒドロカルボスチ
リル
融点:106.5−108℃
融点:148−149℃(トルエンから1回およびエタ
ノールから1回再結晶) [Table] It has been recognized that carbostyril of the general formula can also be prepared according to the following method. General formula appropriately formed in the reaction mixture (In the formula, D, W, R 1 to R 4 and m are the same as defined above, and Z represents a nucleophilically convertible group such as a hydroxy group, a halogen atom, alkoxy, aryloxy or aralkoxy group) Cyclization of the compound. The cyclization is carried out in the presence of a condensing agent such as sulfuric acid, concentrated hydrochloric acid, phosphoric acid or thionyl chloride as appropriate, in a solvent such as glacial acetic acid, tetrahydrofuran, dioxane, chloroform, triene, ethanol or in an excess of condensing agent used. at elevated temperatures, for example between 50 and 200°C, but preferably
Preferably it is carried out at a temperature between 80 and 150°C.
However, the reaction can also be carried out without solvent and/or condensing agent. It is not necessary to isolate the compound of the general formula and use it as is as a starting material. This compound can be prepared in situ from the corresponding nitro compound by, for example, reducing the nitro group with hydrogen in the presence of a hydrogenation catalyst such as palladium-charcoal, palladium-calcium carbonate or palladium-calcium carbonate plus lead acetate (Rindler's catalyst). Thus, by reduction with metals such as iron, tin or zinc in the presence of acids, salts such as iron()-sulfate, zinc()-chloride, chromium()-chloride or dithionite can be prepared. by reduction with sodium hydrazine or by reduction with hydrazine in the presence of Raney-nickel. When m represents 1 in the corresponding nitro compound, the reduction of the nitro group is carried out with an equivalent amount of the necessary reducing agent.
For example with metal salts such as iron-()-sulfate, tin-()-chloride, chromium-()-chloride or sodium dithionite or in the presence of a hydrogenation catalyst deactivated with hydrogen, e.g. palladium
It is appropriate to conduct this in the presence of calcium carbonate + lead acetate. If, for example, this reduction is carried out in the presence of palladium-charcoal, the sulfoxide groups will also be partially reduced. Furthermore, if W in the corresponding nitro compound represents a vinylene group, this group can be converted into the corresponding ethylene group by hydrogenation, in particular the reduction catalytically with activated hydrogen, for example palladium- This is the case when carried out with hydrogen in the presence of charcoal. The compounds of the general formula used as starting materials are partly known from the literature and they can be obtained by known methods. That is, compounds of the general formula are obtained by reducing the corresponding nitro compounds, which in turn are obtained by alkylating the corresponding 2-nitro-5-hydroxy compounds with the corresponding α,ω dihalogen alkanes, and then by reducing the corresponding nitro compounds. by reaction with a mercapto compound and optionally subsequent oxidation with hydrogen peroxide. The following examples illustrate the invention. Example 1 (Reference example) 6-[4-(2-pyridylsulfonyl)-butoxy]-3,4-dihydro-carbostyryl (a) 2-nitro-5-hydroxy-cinnamic acid methyl ester 21.0 g of 2- Nitro-5-hydroxy-cinnamic acid [S. N. Chakravertei (SN
Chakravarti) and PLNRao, Chem. Sasa. (Chem.Soc.)
1938, 172] in 200 ml of methanol.
Add 86 ml of thionyl chloride to this solution while stirring.
Add dropwise within 45 minutes, at a temperature of 36°C.
It can be raised to After stirring for a further 25 minutes, the reaction mixture is cooled on an ice bath to obtain 18.6 g of 2-nitro-5-hydroxy-cinnamate methyl-ester. Melting point: 201-203℃. (b) 2-Nitro-5-bromobutoxy-cinnamic acid methyl ester 22.3 g 2-nitro-5-hydroxy-cinnamic acid methyl ester, 59.7 ml 1,4-dibromobutane and 13.8 g in 200 ml dimethyl sulfoxide. A mixture of 15 g of potassium carbonate at room temperature
Stir for an hour. After adding 800 ml of water, the reaction mixture is extracted with chloroform and, after evaporation of the solvent, 31.7 g of 2-nitro-5-brombutoxy-cinnamate methyl ester are isolated. Melting point: 60.5-63℃. (c) 2-Nitro-5-[4-(2-pyridylmercapto)-butoxy]-cinnamic acid methyl ester A mixture of 5 g potassium carbonate and 4.0 g 2-mercaptopyridine in 100 ml dimethyl sulfoxide for 60 minutes. After stirring, add 10.75g of 2
-Nitro-5-bromo-butoxy-cinnamic acid methyl ester is added and the mixture is stirred at room temperature for 18
Stir for an hour. 400 ml of water are added and the oily reaction product is isolated by ether extraction. Yield: 11.0g (94.2% of theory). (d) 2-nitro-5-[4-(2-pyridylsulfonyl)-butoxy]-cinnamate methyl ester 7.0 g of 2-nitro-5-[4-(2-pyridylmercapto)-butoxy]-cinnamate methyl ester Dissolve the acid methyl ester in 70 ml of acetic acid. 35% of 5.0ml
Hydrogen peroxide is added and the mixture is kept at room temperature for 3 days. After distilling off the glacial acetic acid, the reaction product is recrystallized from chloroform/methanol. Yield: 3.5g (46.2% of theory). Melting point: 118-121℃. (e) 6-[4-(2-pyridylsulfonyl)-butoxy]-3,4-dihydrocarbostyryl 2.1 g of 2-nitro-5-[4-(2-pyridylsulfonyl)-butoxy]-cinnamic acid Dissolve methyl ester in 20ml of glacial acetic acid and add 0.5g of this
hydrogenation using 10% palladium on charcoal at 3 bar hydrogen pressure at room temperature. After distilling off the glacial acetic acid,
The residue is refluxed with 20 ml of concentrated hydrochloric acid for 4 hours. The reaction product was neutralized with 2N sodium hydroxide solution,
and extract with chloroform. The evaporation residue is recrystallized from xylene. Yield: 1.06g (55.6% of theory). Melting point: 121-123℃. Example 2 (Reference example) 6-[4-(2-pyridylsulfonyl)-butoxy]-carbostyryl 2.0 g of 2-nitro-5-[4-(2-pyridylsulfonyl)-butoxy]-cinnamate methyl ester and 3.0 g of sodium dithionite.
Reflux in 20 ml water and 10 ml ethanol for 4 hours to obtain a clear solution. The reaction mixture is evaporated and refluxed for 3 hours with 20 ml of concentrated hydrochloric acid. 2n
After neutralization with sodium hydroxide solution, the reaction product is extracted with ether and recrystallized from xylene by addition of a small amount of dimethylformamide. Yield: 0.5g (29% of theory) Melting point: 176-179°C. This material can be obtained in a similar manner using a Lindlar catalyst (palladium partially inactivated by lead) instead of sodium dithionite as reducing agent. Thereby, only the nitro group is reduced, and 6-[4-(2-pyridylsulfonyl)
-butoxy]-carbostyril is obtained after treatment with concentrated hydrochloric acid. Example 3 (Reference example) 6-[4-(3,4-dichlorophenylmercapto)-butoxy]-carbostyryl 4.5 g of 2-nitro-5-[4-(3,4-dichlorophenylmercapto)- butoxy]-cinnamic acid methyl ester (melting point: 91-92℃, 2-nitro-
5-Hydroxy-cinnamate methyl-ester and 4
-(3,4-dichlorophenylmercapto)-butyl-bromide) is refluxed for 4 hours in a mixture of 50 ml of ethanol and 50 ml of water. After removing the solvent, the residue is refluxed for 4 hours with 100 ml of concentrated hydrochloric acid. The crystalline material obtained is filtered by absorption and recrystallized from xylene. Yield: 1.2g (31% of theory). Melting point: 144℃. Example 4 6-[4-(3,4-dichlorophenyl-sulfinyl)-butoxy]-carbostyryl(a) 2-nitro-5-[4-(3,4-dichlorophenyl-sulfinyl)-butoxy]- Cinnamic acid methyl ester 11.2 g of 2-nitro-5-hydroxy-cinnamic acid methyl ester are dissolved in 150 ml of dimethyl sulfoxide. This solution is mixed with 9.2 g of anhydrous potassium carbonate and stirred for 15 minutes.
16.5 g of 4-(3,4-dichlorophenylsulfinyl)-butyl bromide are added and the mixture is stirred for 40 hours at room temperature. reaction mixture
Dilute with 1000 ml of water and extract with a mixture of 200 ml of chloroform and 100 ml of methanol.
Evaporation of the organic solvent yields an oily residue,
On treatment with ether it is obtained in crystalline form. Yield: 13g (57% of theory). Melting point: 78-81°C (b) 2-Amino-5-[4-(3,4-dichlorophenylsulfinyl)-butoxy]-cinnamate methyl ester 4.2 g of 2-nitro-5-[4 -(3,4-dichlorophenylsulfinyl)-butoxy]-cinnamate methyl ester was prepared in 100 ml of methanol with 0.5 g of Lindlar's catalyst (palladium partially deactivated by lead acetate). Hydrogenate with calcium carbonate) at a hydrogen pressure of 3 bar for 12 hours at room temperature. After removing the catalyst, the solvent is evaporated and the resinous dark residue is used directly in the next reaction. (c) 6-[4-(3,4-dichlorophenylsulfinyl)-butoxy]-carbostyryl The above-mentioned 2-amino-5-[4-(3,4-dichlorophenylsulfinyl)- [butoxy]-cinnamic acid methyl ester is heated to boiling for 3 hours with 80 ml of 5N hydrochloric acid and filtered hot. After cooling the filtrate, colorless crystals are obtained. Yield: 2.1 g (56% of theory). Melting point: 191-192℃. In the above reaction method, if iron powder and 80% acetic acid are used as the ring group of 2-nitro-5-[4-(3,4-dichlorophenylsulfinyl)-butoxy]-cinnamate methyl ester, too,
Furthermore, 6-[4-(3,4-dichlorophenylsulfinyl)-butoxy]-carbostyryl is obtained as a reaction product. Example 5 2.3 g of 2-nitro-5-(3,4-dichlorophenylsulfinyl)-butoxy-cinnamic acid methyl ester are dissolved in 20 ml of glacial acetic acid as in Example 5b.
Hydrogenation is carried out using 0.2 g of palladium on charcoal at a hydrogen pressure of 3 bar for 7 hours at room temperature. After removing the catalyst, the glacial acetic acid was distilled off and the residue was poured into 40 ml of
Heat with 5N hydrochloric acid until boiling for 1 hour.
The reaction mixture is extracted with a small amount of chloroform and chromatographed on thin layer plates (Merck silica gel 60F 254 ) with ethylene chloride/methanol 9:1. The obtained compound
Confirm by spraying with UV-light and iodine spray. Rf value: 0.30: 6-[4-(3,4-dichlorophenylsulfinyl)-butoxy]-carbostyryl. Blue-violet color with iodine spray. Rf value: 0.42: 6-[4-(3,4-dichlorophenylmercapto)-butoxy]-carbostyryl.
Iodine spray turns orange-yellow at first, then gradually gray-
Violet. Rf value: 0.45: 6-[4-(3,4-dichlorophenyl-sulfinyl)-butoxy]-3,4-dihydro-carbostyryl. Strong orange-yellow color with iodine spray. Rf value: 0.57: 6-[4-(3,4-dichlorophenyl-mercapto)-butoxy]-3,4-dihydro-carbostyryl. Pale egg yellow with iodine spray. The following compounds are prepared analogously to the above examples. 6-(4-phenylsulfinylbutoxy)-
3,4-dihydrocarbostyryl melting point: 144.5-145.5°C 6-[4-(2-pyridylsulfinyl)-butoxy]-3,4-dihydrocarbostyryl melting point: 144.5-146°C. 6-(2-phenylsulfinyl-ethoxy)-
3,4-dihydro-carbostyryl Melting point: 171-172°C 6-(4-benzylsulfinyl-butoxy)-
3,4-dihydrocarbostyryl Melting point: 141.5-142℃ 6-[4-(4-chlorophenylsulfinyl)
-butoxy]-3,4-dihydrocarbostyril melting point: 148-149.5°C 6-(4-cyclohexylsulfinyl-butoxy)-3,4-dihydrocarbostyryl melting point: 153-155.5°C 6-[4-(2 -naphthylsulfinyl)-butoxy]-3,4-dihydrocarbostyryl melting point: 147.5-148.5°C 6-[4-(2-methoxyphenylsulfinyl)-butoxy]-3,4-dihydrocarbostyryl melting point: 130.5-133℃ 6-(4-phenylsulfinyl-butoxy)-
Carbostyril melting point: 181-182.5℃ 6-[4-(4-hydroxy-3,5-di-tert
-butyl-phenylsulfinyl)-butoxy]-
Carbostyril melting point: 192-194℃ 6-[4-(3,4-dichlorophenylsulfinyl)-butoxy]-carbostyril melting point: 191-196℃ 4-methyl-6-(4-phenylsulfinyl -butoxy)-carbostyril melting point: 167-168℃ 6-[4-(2,5-dichlorophenylsulfinyl)-butoxy]-3,4-dihydrocarbostyril melting point: 185-186℃ 6-[4 -(2-naphthyl-sulfinyl)-butoxy]-3,4-dihydrocarbostyryl Melting point: 147.5-148.5°C 6-[4-(4-biphenylylsulfinyl)-
Butoxy]-carbostyril melting point: 196-197℃ 6-[4-(2-quinolylsulfinyl)-butoxy]-carbostyril melting point: 197-198℃ 6-[4-cyclohexylsulfinyl)-butoxy] -Carbostyril melting point: 169-170℃ 5-bromo-6-(4-phenylsulfinyl-butoxy)-carbostyril melting point: 190-191℃ 6-[4-(3,5-dibromo-4-aminophene) 6-[4-(3,5-dibromo-4-aminophenylsulfinyl)-butoxy]-carbostyryl Melting point: 205 -207℃ 6-[4-(4-cyclohexylphenylsulfinyl)-butoxy]-3,4-dihydrocarbostyryl Melting point: 155-157℃ 6-[4-(4-cyclohexylphenylsulfinyl)-butoxy ]-Carbostyril melting point: 188-190℃ 6-[4-(4-tert-butylphenylsulfinyl)-butoxy]-carbostyril melting point: 164-166℃ 6-[4-(3,4-dichlor Phenylsulfinyl)-butoxy]-3,4-dihydrocarbostyryl Melting point: 106.5-108°C Melting point: 148-149°C (recrystallized once from toluene and once from ethanol)
Claims (1)
チル−ビニレン基を表わし、Dは2〜6個の炭素
原子を有する直鎖状もしくは分枝状アルキレン基
を表わし、mは1を表わし、R1は水素原子を表
わし、R2は3〜6個の炭素原子を有するシクロ
アルキル基、フエニル基、ナフチル基、フエニル
アルキル基、ピリジル基またはキノリル基を表わ
し(但し上記の芳香族核はアルキル、ヒドロキ
シ、メトキシ、アミノ、シクロヘキシル、フエニ
ル又はハロゲン原子によつて置換されていてもよ
い)、そしてR3およびR4は同一でも異なつていて
もよく、水素原子、ハロゲン原子またはアルキル
基を表わす〕 で示されるカルボスチリル誘導体の製造方法であ
つて、一般式 (式中D、W、R1〜R4およびmは上記の定義と
同じであり、そしてZは求核的に交換しうる基を
表わす)で示される化合物を環化することを特徴
とする製造方法。 2 反応を縮合剤たとえば硫酸、濃塩酸、リン酸
又は塩化チオニルの存在下に行なう特許請求の範
囲第1項の方法。 3 反応を50と200℃の間の温度で、好ましくは
80と150℃との間の温度で行なう、特許請求の範
囲第1項および第2項のいずれか一項の方法。 4 反応を溶媒中で行なう、特許請求の範囲第1
項、第2項および第3項のいずれか一項の方法。[Claims] 1. General formula [In the formula, W represents a vinylene group, ethylene group or 2-methyl-vinylene group, D represents a linear or branched alkylene group having 2 to 6 carbon atoms, m represents 1, R 1 represents a hydrogen atom, and R 2 represents a cycloalkyl group, phenyl group, naphthyl group, phenylalkyl group, pyridyl group, or quinolyl group having 3 to 6 carbon atoms (however, the above aromatic nucleus is an alkyl group). , hydroxy, methoxy, amino, cyclohexyl, phenyl or halogen atoms), and R 3 and R 4 may be the same or different and represent a hydrogen atom, a halogen atom or an alkyl group ] A method for producing a carbostyryl derivative represented by the general formula (wherein D, W, R 1 to R 4 and m are the same as defined above, and Z represents a nucleophilically exchangeable group) is characterized by cyclizing the compound represented by Production method. 2. A process according to claim 1, wherein the reaction is carried out in the presence of a condensing agent such as sulfuric acid, concentrated hydrochloric acid, phosphoric acid or thionyl chloride. 3. The reaction is carried out at a temperature between 50 and 200°C, preferably
3. The method of any one of claims 1 and 2, carried out at a temperature between 80 and 150<0>C. 4 Claim 1 in which the reaction is carried out in a solvent
2. The method of any one of paragraphs 2 and 3.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19792928583 DE2928583A1 (en) | 1979-07-14 | 1979-07-14 | Substd. alkoxy-carbostyril derivs prodn. - e.g. by cyclising 2-carboxyethyl-1-aminobenzene derivs., useful as antithrombotic and positive inotropic agents |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5616470A JPS5616470A (en) | 1981-02-17 |
| JPS6326751B2 true JPS6326751B2 (en) | 1988-05-31 |
Family
ID=6075786
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP6999180A Granted JPS5616470A (en) | 1979-07-14 | 1980-05-26 | Novel manufacture of carbostyril derivative |
Country Status (5)
| Country | Link |
|---|---|
| JP (1) | JPS5616470A (en) |
| DE (1) | DE2928583A1 (en) |
| DK (1) | DK150156C (en) |
| FI (1) | FI70408C (en) |
| NO (1) | NO154131C (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI77852C (en) * | 1981-02-17 | 1989-05-10 | Otsuka Pharma Co Ltd | Process for the preparation of novel, such as cardiac drugs, useful s unsubstituted amide and (saturated heterocycle) carbonyl carbostyril derivatives. |
| US4442111A (en) * | 1981-07-25 | 1984-04-10 | Dr. Karl Thomae Gesellschaft Mit Beschrankter Haftung | Antithrombotic sulfimino and sulfoximino indolinones-2 |
| AU532361B2 (en) * | 1981-09-01 | 1983-09-29 | Otsuka Pharmaceutical Co., Ltd. | Carbostyril derivatives |
| DK167187A (en) * | 1986-04-02 | 1987-10-03 | Otsuka Pharma Co Ltd | CARBOSTYRIC DERIVATIVES AND SALTS THEREOF, PROCEDURE FOR THE PREPARATION OF SUCH COMPOUNDS AND MEDICINAL CONTAINING THESE |
| KR940000785B1 (en) * | 1986-04-02 | 1994-01-31 | 오오쓰까세이야꾸 가부시끼가이샤 | Method for preparing carbostyryl derivatives and salts thereof |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5321176A (en) * | 1976-08-09 | 1978-02-27 | Otsuka Pharmaceut Co Ltd | Carbostyryl derivatives |
-
1979
- 1979-07-14 DE DE19792928583 patent/DE2928583A1/en not_active Withdrawn
- 1979-08-03 FI FI792426A patent/FI70408C/en not_active IP Right Cessation
- 1979-08-15 NO NO792659A patent/NO154131C/en unknown
- 1979-08-15 DK DK342079A patent/DK150156C/en not_active IP Right Cessation
-
1980
- 1980-05-26 JP JP6999180A patent/JPS5616470A/en active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| DE2928583A1 (en) | 1981-01-29 |
| NO154131B (en) | 1986-04-14 |
| NO792659L (en) | 1981-01-15 |
| FI70408C (en) | 1986-09-19 |
| DK342079A (en) | 1981-01-15 |
| NO154131C (en) | 1986-07-23 |
| FI70408B (en) | 1986-03-27 |
| DK150156C (en) | 1987-10-12 |
| JPS5616470A (en) | 1981-02-17 |
| DK150156B (en) | 1986-12-22 |
| FI792426A7 (en) | 1981-01-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Fehnel | Friedländer syntheses with o‐aminoaryl ketones. III. Acid‐catalyzed condensations of o‐aminobenzophenone with polyfunctional carbonyl compounds | |
| Geissman et al. | The synthesis of some intermediates for use in the preparation of analogs of salicylaldehyde ethylenediimine cobalt (“salcomine”) | |
| US3484445A (en) | Derivatives of chromone-2-carboxylic acid | |
| NO760993L (en) | ||
| Hansch et al. | The ortho effect in plant growth-regulators | |
| Kosak et al. | The Synthesis and Properties of the 5-Phenyl-2-and 3-thiophene-ols1 | |
| Bachmann et al. | Methyl derivatives of 3, 4-benzpyrene. The Willgerodt reaction on some 3-acylpyrenes | |
| Campbell et al. | Studies in the Quinoline Series. V. The Preparation of Some α-Dialkylaminomethyl-2-quinolinemethanols1 | |
| JPS6326751B2 (en) | ||
| Bisagni et al. | Oxygen heterocycles. Part III. The reactivity of Benzofuran and 2-alkylbenzofurans | |
| CA1199635A (en) | Derivatives of benzofuranones | |
| Kwartler et al. | Condensation reactions of quinoline aldehydes | |
| Fieser et al. | The n-methylformanilide synthesis of aldehydes | |
| Yates et al. | Carbon disulfide. II. Reaction with active methylene compounds. The structures of the desaurins | |
| Raiford et al. | Preparation of α, β-unsaturated ketones and their reaction with phenylhydrazine | |
| JPS5943949B2 (en) | N-substituted derivatives of moranoline | |
| US3506658A (en) | 2-(10-methyl-2-phenoxazinyl)propionic acid | |
| GB2047698A (en) | 6-substituted pyranone compounds and their use as pharmaceuticals | |
| US2558211A (en) | Preparation of 4-hydroxyquinoline compounds | |
| Rossiter et al. | 736. Studies in the pyrrocoline series | |
| KR840002103B1 (en) | Method for preparing carbostyryl derivative | |
| HU177522B (en) | Process for preparing new carbostyril and oxindole derivatives | |
| US3062834A (en) | Process for preparing thiophencarboxylic acids and their esters | |
| Buu-Hoi et al. | 98. Methyl β-naphthyl sulphide | |
| US2073683A (en) | Diphenyl derivatives |